Emerging roles of pulmonary macrophages in driving the development of severe asthma

Journal of Leukocyte Biology

Volumn 91, Issue 4, 2012, Pages 557-569

  Yang, Ming ^a   Kumar, Rakesh K ^b   Hansbro, Philip M ^a   Foster, Paul S ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Airway hyper responsiveness; Innate immunity; Steroid resistance

Indexed keywords

GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 33; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ASTHMA; BACTERIAL INFECTION; BRONCHUS HYPERREACTIVITY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; HUMAN; IMMUNOPATHOGENESIS; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; ASTHMA; CYTOKINES; DRUG RESISTANCE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; MACROPHAGES, ALVEOLAR; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

EID: 84860877293     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0711357     Document Type: Review

References (191)

1. Cohn, L., Elias, J. A., Chupp, G. L. (2004) Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22, 789-815.
2. Hansbro, P. M., Kaiko, G. E., Foster, P. S. (2011) Cytokine/anti-cytokine therapy-novel treatments for asthma? Br. J. Pharmacol. 163, 81-95.
3. Barnes, P. J., Adcock, I. M. (2009) Glucocorticoid resistance in inflammatory diseases. Lancet 373, 1905-1917.
4. Wang, W., Li, J. J., Foster, P. S., Hansbro, P. M., Yang, M. (2010) Potential therapeutic targets for steroid-resistant asthma. Curr. Drug Targets 11, 957-970.
5. Wenzel, S. E., Szefler, S. J., Leung, D. Y., Sloan, S. I., Rex, M. D., Martin, R. J. (1997) Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am. J. Respir. Crit. Care Med. 156, 737-743.
6. Hansbro, N. G., Horvat, J. C., Wark, P. A., Hansbro, P. M. (2008) Understanding the mechanisms of viral induced asthma: new therapeutic directions. Pharmacol. Ther. 117, 313-353.
7. Al-Ramli, W., Prefontaine, D., Chouiali, F., Martin, J. G., Olivenstein, R., Lemiere, C., Hamid, Q. (2009) T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J. Allergy Clin. Immunol. 123, 1185-1187.
8. Goleva, E., Hauk, P. J., Hall, C. F., Liu, A. H., Riches, D. W., Martin, R. J., Leung, D. Y. (2008) Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. J. Allergy Clin. Immunol. 122, 550-559.e3.
9. Horvat, J. C., Starkey, M. R., Kim, R. Y., Beagley, K. W., Preston, J. A., Gibson, P. G., Foster, P. S., Hansbro, P. M. (2010) Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease. J. Immunol. 184, 4159-4169.
10. Hansbro, P. M., Beagley, K. W., Horvat, J. C., Gibson, P. G. (2004) Role of atypical bacterial infection of the lung in predisposition/protection of asthma. Pharmacol. Ther. 101, 193-210.
11. Essilfie, A. T., Simpson, J. L., Horvat, J. C., Preston, J. A., Dunkley, M. L., Foster, P. S., Gibson, P. G., Hansbro, P. M. (2011) Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLoS Pathog. 7, e1002244.
12. Essilfie, A. T., Simpson, J. L., Dunkley, M. A., Morgan, L. C., Oliver, B. G., Gibson, P. G., Foster, P. S., Hansbro, P. M. (2012) Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of steroid-resistant neutrophilic asthma. Thorax, 2011, 7(1):e1002244.
13. Eder, W., Ege, M. J., von Mutius, E. (2006) The asthma epidemic. N. Engl. J. Med. 355, 2226-2235.
14. Douwes, J., Gibson, P., Pekkanen, J., Pearce, N. (2002) Non-eosinophilic asthma: importance and possible mechanisms. Thorax 57, 643-648.
15. Simpson, J. L., Scott, R. J., Boyle, M. J., Gibson, P. G. (2005) Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am. J. Respir. Crit. Care Med. 172, 559 -565.
16. Bousquet, J., Mantzouranis, E., Cruz, A. A., Ait-Khaled, N., Baena-Cag-nani, C. E., Bleecker, E. R., Brightling, C. E., Burney, P., Bush, A., Busse, W. W., Casale, T. B., Chan-Yeung, M., Chen, R., Chowdhury, B., Chung, K. F., Dahl, R., Drazen, J. M., Fabbri, L. M., Holgate, S. T., Kauffmann, F., Haahtela, T., Khaltaev, N., Kiley, J. P., Masjedi, M. R., Mohammad, Y., O'Byrne, P., Partridge, M. R., Rabe, K. F., Togias, A., van Weel, C., Wenzel, S., Zhong, N., Zuberbier, T. (2010) Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J. Allergy Clin. Immunol. 126, 926-938.
17. Corrigan, C. J., Kay, A. B. (1991) CD4 T lymphocyte activation in acute severe asthma. Int. Arch. Allergy Appl. Immunol. 94, 270-271.
18. European Network for Understanding Mechanisms of Severe Asthma. (2003) The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur. Respir. J. 22, 470-477.
19. Wenzel, S. E., Busse, W. W. (2007) Severe asthma: lessons from the Severe Asthma Research Program. J. Allergy Clin. Immunol. 119, 14-21.
20. British Thoracic Society Scottish Intercollegiate Guidelines Network. (2008) British Guideline on the Management of Asthma. Thorax 63 (Suppl. 4), 41-121.
21. Sont, J. K, Willems, L. N., Bel, E. H., van Krieken, J. H., Vandenb-roucke, J. P., Sterk, P.J. (1999) Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am. J. Respir Crit. Care Med. 159, 1043-1051.
22. Meurs, H., Gosens, R., Zaagsma, J. (2008) Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models. Eur Respir. J. 32, 487-502.
23. Horvat, J. C, Starkey, M. R, Kim, R Y., Phipps, S., Gibson, P. G., Bea-gley, K. W., Foster, P. S., Hansbro, P. M. (2010) Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology. J. Allergy Clin. Immunol. 125, 617-625, 625.e1-625.e6.
24. Horvat, J. C, Beagley, K. W., Wade, M. A, Preston, J. A, Hansbro, N. G., Hickey, D. K, Kaiko, G. E., Gibson, P. G., Foster, P. S., Hansbro, P. M. (2007) Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am. J. Respir. Crit. Care Med. 176, 556-564.
25. Kay, A. B. (2001) Allergy and allergic diseases. First of two parts. N. Engl. J. Med. 344, 30-37.
26. Kariyawasam, H. H., Aizen, M., Barkans, J., Robinson, D. S., Kay, A. B. (2007) Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. Am. J. Respir. Crit. Care Med. 175, 896-904.
27. Galli, S. J. (1993) New concepts about the mast cell. N. Engl. J. Med. 328, 257-265.
28. Frew, A J., Moqbel, R, Azzawi, M., Hartnell, A, Barkans, J., Jeffery, P. K, Kay, A. B., Scheper, R J., Varley, J., Church, M. K, et al. (1990) T lymphocytes and eosinophils in allergen-induced late-phase asthmatic reactions in the guinea pig. Am. Rev. Respir. Dis. 141, 407-413.
29. Broide, D. H., Gleich, G. J., Cuomo, A J., Coburn, D. A, Federman, E. C, Schwartz, L. B., Wasserman, S. I. (1991) Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J. Allergy Clin. Immunol. 88, 637-648.
30. Walker, C, Kaegi, M. K, Braun, P., Blaser, K. (1991) Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J. Allergy Clin. Immunol. 88, 935-942.
31. Currie, G. P., Lee, D. K, Wilson, A. M. (2005) Effects of dual therapy with corticosteroids plus long acting β2-agonists in asthma. Respir. Med. 99, 683-694.
32. Fanta, C. H. (2009) Asthma. N. Engl. J. Med. 360, 1002-1014.
33. Anderson, G. P. (2008) Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372, 1107-1119.
34. Barnes, P. J., Woolcock, A.J. (1998) Difficult asthma. Eur. Respir. J. 12, 1209-1218.
35. Rhen, T., Cidlowski, J. A. (2005) Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N. Engl. J. Med. 353, 1711-1723.
36. Mak, J. C, Hisada, T., Salmon, M., Barnes, P. J., Chung, K. F. (2002) Glucocorticoids reverse IL-1β-induced impairment ofβ-adrenoceptor-mediated relaxation and up-regulation of G-protein-coupled receptor kinases. Br. J. Pharmacol. 135, 987-996.
37. Goleva, E., Kisich, K. O., Leung, D. Y. (2002) A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. J. Immunol. 169, 5934-5940.
38. Barnes, P. J. (2006) Corticosteroids: the drugs to beat. Eur. J. Pharmacol. 533, 2-14.
39. Peterson, C. L., Laniel, M. A. (2004) Histones and histone modifications. Curr. Biol. 14, R546-R551.
40. Kagoshima, M., Wilcke, T., Ito, K, Tsaprouni, L., Barnes, P. J., Punchard, N., Adcock, I. M. (2001) Glucocorticoid-mediated transre-pression is regulated by histone acetylation and DNA methylation. Eur J. Pharmacol. 429, 327-334.
41. Matthews, J. G., Ito, K, Barnes, P. J., Adcock, I. M. (2004) Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J. Allergy Clin. Immunol. 113, 1100-1108.
42. Vreugdenhil, E., Verissimo, C. S., Mariman, R, Kamphorst, J. T., Bar-bosa, J. S., Zweers, T., Champagne, D. L., Schouten, T., Meijer, O. C, de Kloet, E. R., Fitzsimons, C. P. (2009) MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology 150, 2220-2228.
43. Uchida, S., Nishida, A, Hara, K, Kamemoto, T., Suetsugi, M., Fujimoto, M., Watanuki, T., Wakabayashi, Y, Otsuki, K, McEwen, B. S., Watanabe, Y (2008) Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. Eur. J. Neurosci. 27, 2250-2261.
44. Kotani, A., Ha, D., Hsieh, J., Rao, P. K, Schotte, D., den Boer, M. L., Armstrong, S. A, Lodish, H. F. (2009) miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221. Blood 114, 4169-4178.
45. Zhang, Y., Miao, J., Hanley, G., Stuart, C, Sun, X., Chen, T., Yin, D. (2008) Chronic restraint stress promotes immune suppression through Toll-like receptor 4-mediated phosphoinositide 3-kinase signaling. J. Neu-roimmunol. 204, 13-19.
46. Powell, N. D., Bailey, M. T., Mays, J. W., Stiner-Jones, L. M., Hanke, M. L., Padgett, D. A, Sheridan, J. F. (2009) Repeated social defeat activates dendritic cells and enhances Toll-like receptor dependent cytokine secretion. Brain Behav. Immun. 23, 225-231.
47. Marwick, J. A, Caramori, G., Stevenson, C. S., Casolari, P., Jazrawi, E., Barnes, P. J., Ito, K, Adcock, I. M., Kirkham, P. A, Papi, A. (2009) Inhibition of PI3Kδ restores glucocorticoid function in smoking-induced airway inflammation in mice. Am. J. Respir. Crit. Care Med. 179, 542-548.
48. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
49. Kaiko, G. E., Horvat, J. C, Beagley, K. W., Hansbro, P. M. (2008) Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunology 123, 326-338.
50. Taylor, P. R, Martinez-Pomares, L., Stacey, M., Lin, H. H., Brown, G D., Gordon, S. (2005) Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23, 901-944.
51. Mosser, D. M., Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
52. Schulman, E. S., Liu, M. C, Proud, D., MacGlashan Jr., D. W., Lichten-stein, L. M., Plaut, M. (1985) Human lung macrophages induce histamine release from basophils and mast cells. Am. Rev. Respir. Dis. 131, 230-235.
53. Engels, F., Oosting, R S., Nijkamp, F. P. (1985) Pulmonary macrophages induce deterioration of guinea-pig tracheal β-adrenergic function through release of oxygen radicals. Eur. J. Pharmacol. 111, 143-144.
54. Tamaoki, J., Sekizawa, K, Ueki, I. F., Graf, P. D., Nadel, J. A, Bigby, T. D. (1987) Effect of macrophage stimulation on parasympathetic airway contraction in dogs. Eur. J. Pharmacol. 138, 421-425.
55. Blussé van Oud Alblas, A., Mattie, H., van Furth, R. (1983) A quantitative evaluation of pulmonary macrophage kinetics. Cell Tissue Kinet. 16, 211-219.
56. Bowden, D. H., Adamson, I. Y. (1980) Role of monocytes and interstitial cells in the generation of alveolar macrophages I. Kinetic studies of normal mice. Lab. Invest. 42, 511-517.
57. Thepen, T., Van Rooijen, N., Kraal, G. (1989) Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J. Exp. Med. 170, 499-509.
58. Van Rijt, L. S., Kuipers, H., Vos, N., Hijdra, D., Hoogsteden, H. C, Lam-brecht, B. N. (2004) A rapid flow cytometric method for determining the cellular composition of bronchoalveolar lavage fluid cells in mouse models of asthma. J. Immunol. Methods 288, 111-121.
59. Van Rijt, L. S., Jung, S., Kleinjan, A, Vos, N., Willart, M., Duez, C, Hoogsteden, H. C, Lambrecht, B. N. (2005) In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J. Exp. Med. 201, 981-991.
60. Grundy, M., Sentman, C. L. (2005) GFP transgenic mice show dynamics of lung macrophages. Exp. Cell. Res. 310, 409-416.
61. Gonzalez-Juarrero, M., Shim, T. S., Kipnis, A, Junqueira-Kipnis, A. P., Orme, I. M. (2003) Dynamics of macrophage cell populations during murine pulmonary tuberculosis.J. Immunol. 171, 3128-3135.
62. Bosio, C. M., Goodyear, A. W., Dow, S. W. (2005) Early interaction of Yersinia pestis with APCs in the lung. J. Immunol. 175, 6750-6756.
63. Gordon, S., Taylor, P. R (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
64. Huynh, M. L., Malcolm, K. C, Kotaru, C, Tilstra, J. A, Westcott, J. Y, Fadok, V A, Wenzel, S. E. (2005) Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages. Am. J. Respir. Crit. Care Med. 172, 972-979.
65. Peters-Golden, M. (2004) The alveolar macrophage: the forgotten cell in asthma. Am. J. Respir. Cell Mol. Biol. 31, 3-7.
66. Herbert, C, Scott, M. M., Scruton, K. H., Keogh, R P., Yuan, K. C, Hsu, K, Siegle, J. S., Tedla, N., Foster, P. S., Kumar, R K. (2010) Alveolar macrophages stimulate enhanced cytokine production by pulmonary CD4+ T-lymphocytes in an exacerbation of murine chronic asthma. Am. J. Pathol. 177, 1657-1664.
67. Mantovani, A, Sica, A, Sozzani, S., Allavena, P., Vecchi, A, Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686.
68. Murray, P. J., Wynn, T. A. (2011) Obstacles and opportunities for understanding macrophage polarization. J. Leukoc. Biol. 89, 557-563.
69. Martinez, F. O., Gordon, S., Locati, M., Mantovani, A. (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303-7311.
70. Mantovani, A. (2008) From phagocyte diversity and activation to probi-otics: back to Metchnikoff Eur. J. Immunol. 38, 3269-3273.
71. Stein, M., Keshav, S., Harris, N., Gordon, S. (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287-292.
72. Kim, E. Y, Battaile, J. T., Patel, A. C, You, Y, Agapov, E., Grayson, M. H., Benoit, L. A, Byers, D. E., Alevy, Y, Tucker, J., Swanson, S., Tidwell, R, Tyner, J. W, Morton, J. D., Castro, M., Polineni, D., Patterson, G. A, Schwendener, R A, Allard, J. D., Peltz, G., Holtzman, M.J. (2008) Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 14, 633-640.
73. Melgert, B. N., Oriss, T. B., Qi, Z., Dixon-McCarthy, B., Geerlings, M., Hylkema, M. N., Ray, A. (2010) Macrophages: regulators of sex differences in asthma? Am. J. Respir. Cell Mol. Biol. 42, 595-603.
74. Biswas, S. K, Mantovani, A. (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889-896.
75. Pope, S. M., Fulkerson, P. C, Blanchard, C, Akei, H. S., Nikolaidis, N. M., Zimmermann, N., Molkentin, J. D., Rothenberg, M. E. (2005) Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation. J. Biol. Chem. 280, 13952-13961.
76. Kodelja, V, Muller, C, Politz, O., Hakij, N., Orfanos, C. E., Goerdt, S. (1998) Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 a with a Th2-associated expression pattern. J. Immunol. 160, 1411-1418.
77. Adema, G. J., Hartgers, F., Verstraten, R, de Vries, E., Marland, G., Menon, S., Foster, J., Xu, Y, Nooyen, P., McClanahan, T., Bacon, K. B., Figdor, C. G. (1997) A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387, 713-717.
78. Luzina, I. G., Papadimitriou, J. C, Anderson, R, Pochetuhen, K., Ata-mas, S. P. (2006) Induction of prolonged infiltration of T lymphocytes and transient T lymphocyte-dependent collagen deposition in mouse lungs following adenoviral gene transfer of CCL18. Arthritis Rheum. 54, 2643-2655.
79. Pochetuhen, K, Luzina, I. G., Lockatell, V, Choi, J., Todd, N. W., Ata-mas, S. P. (2007) Complex regulation of pulmonary inflammation and fibrosis by CCL18. Am. J. Pathol. 171, 428-437.
80. De Nadai, P., Charbonnier, A. S., Chenivesse, C, Senechal, S., Fournier, C, Gilet, J., Vorng, H., Chang, Y, Gosset, P., Wallaert, B., Tonnel, A. B., Lassalle, P., Tsicopoulos, A. (2006) Involvement of CCL18 in allergic asthma. J. Immunol. 176, 6286-6293.
81. Kim, H. B., Kim, C. K, Iijima, K, Kobayashi, T., Kita, H. (2009) Protein microarray analysis in patients with asthma: elevation of the chemokine PARC/CCL18 in sputum. Chest 135, 295-302.
82. Nair, M. G., Du, Y, Perrigoue, J. G., Zaph, C, Taylor, J. J., Goldschmidt, M., Swain, G. P., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A, Karow, M., Stevens, S., Pearce, E. J., Artis, D. (2009) Alternatively activated macrophage-derived RELM-{a} is a negative regulator of type 2 inflammation in the lung. J. Exp. Med. 206, 937-952.
83. Chen, H., Jacobson, B. A, Mason, L., Wolf, S. F., Bowman, M. R (2010) FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction. Eur. Respir. J. 36, 1165-1173.
84. Melgert, B. N., ten Hacken, N. H., Rutgers, B., Timens, W., Postma, D. S., Hylkema, M. N. (2011) More alternative activation of macro phages in lungs of asthmatic patients. J. Allergy Clin. Immunol. 127, 831- 833.
85. Subrata, L. S., Bizzintino, J., Mamessier, E., Bosco, A, McKenna, K. L., Wikstrom, M. E., Goldblatt, J., Sly, P. D., Hales, B. J., Thomas, W. R, Laing, I. A, LeSouef, P. N., Holt, P. G. (2009) Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J. Immunol. 183, 2793-2800.
86. Hunninghake, G. M., Cho, M. H., Tesfaigzi, Y, Soto-Quiros, M. E., Avila, L., Lasky-Su, J., Stidley, C, Melen, E., Soderhall, C, Hallberg, J., Kull, I., Kere, J., Svartengren, M., Pershagen, G., Wickman, M., Lange, C, De-meo, D. L., Hersh, C. P., Klanderman, B. J., Raby, B. A, Sparrow, D., Shapiro, S. D., Silverman, E. K, Litonjua, A. A, Weiss, S. T., Celedon, J. C. (2009) MMP12, lung function, and COPD in high-risk populations. N. Engl. J. Med. 361, 2599-2608.
87. Ober, C, Tan, Z., Sun, Y, Possick, J. D., Pan, L., Nicolae, R, Radford, S., Parry, R R, Heinzmann, A, Deichmann, K. A, Lester, L. A, Gern, J. E., Lemanske Jr., R F., Nicolae, D. L., Elias, J. A., Chupp, G. L. (2008) Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N. Engl. J. Med. 358, 1682-1691.
88. Iwashita, H., Morita, S., Sagiya, Y, Nakanishi, A. (2006) Role of eosinophil chemotactic factor by T lymphocytes on airway hyperresponsiveness in a murine model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 35, 103-109.
89. Johansen, J. S., Jensen, B. V, Roslind, A, Price, P. A. (2007) Is YKL-40 a new therapeutic target in cancer? Expert Opin. Ther. Targets 11, 219-234.
90. Chupp, G. L., Lee, C. G., Jarjour, N., Shim, Y M., Holm, C. T., He, S., Dziura, J. D., Reed, J., Coyle, A J., Kiener, P., Cullen, M., Grandsaigne, M., Dombret, M. C, Aubier, M., Pretolani, M., Elias, J. A. (2007) A chiti-nase-like protein in the lung and circulation of patients with severe asthma. N. Engl. J. Med. 357, 2016-2027.
91. Parks, W. C, Shapiro, S. D. (2001) Matrix metalloproteinases in lung biology. Respir. Res. 2, 10-19.
92. Mukhopadhyay, S., Sypek, J., Tavendale, R., Gartner, U., Winter, J., Li, W., Page, K, Fleming, M., Brady, J., O'Toole, M., Macgregor, D. F., Goldman, S., Tam, S., Abraham, W., Williams, C, Miller, D. K., Palmer, C. N. (2010) Matrix metalloproteinase-12 is a therapeutic target for asthma in children and young adults. J. Allergy Clin. Immunol. 126, 70-76.e16.
93. Hume, D. A. (2008) Macrophages as APC and the dendritic cell myth. J. Immunol. 181, 5829-5835.
94. Sutterwala, F. S., Noel, G. J., Salgame, P., Mosser, D. M. (1998) Reversal of proinflammatory responses by ligating the macrophage Fcγ receptor type I.J. Exp. Med. 188, 217-222.
95. Gerber, J. S., Mosser, D. M. (2001) Reversing lipopolysaccharide toxicity by ligating the macrophage Fc 7 receptors.J. Immunol. 166, 6861-6868.
96. Fleming, B. D., Mosser, D. M. (2011) Regulatory macrophages: setting the threshold for therapy. Eur. J. Immunol. 41, 2498-2502.
97. Tang, C, Inman, M. D., van Rooijen, N., Yang, P., Shen, H., Matsumoto, K., O'Byrne, P. M. (2001) Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-γ-dependent mechanism. J. Immunol. 166, 1471-1481.
98. Careau, E., Bissonnette, E. Y. (2004) Adoptive transfer of alveolar macrophages abrogates bronchial hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 31, 22-27.
99. Careau, E., Proulx, L. I., Pouliot, P., Spahr, A, Turmel, V., Bissonnette, E. Y (2006) Antigen sensitization modulates alveolar macrophage functions in an asthma model. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L871-L879.
100. Stolarski, B., Kurowska-Stolarska, M., Kewin, P., Xu, D., Liew, F. Y (2010) IL-33 exacerbates eosinophil-mediated airway inflammation. J. Immunol. 185, 3472-3480.
101. Murray, P. J., Wynn, T. A. (2011) Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737.
102. Maneechotesuwan, K, Supawita, S., Kasetsinsombat, K, Wongkajornsilp, A, Barnes, P.J. (2008) Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids. J. Allergy Clin. Immunol. 121, 43-50.
103. Fitzpatrick, A. M., Higgins, M., Holguin, F., Brown, L. A, Teague, W. G. (2010) The molecular phenotype of severe asthma in children. J. Allergy Clin. Immunol. 125, 851-857.e818.
104. Bedoret, D., Wallemacq, H., Marichal, T., Desmet, C, Quesada Calvo, F., Henry, E., Closset, R, Dewals, B., Thielen, C, Gustin, P., de Leval, L., Van Rooijen, N., Le Moine, A, Vanderplasschen, A, Cataldo, D., Drion, P. V., Moser, M., Lekeux, P., Bureau, F. (2009) Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J. Clin. Invest. 119, 3723-3738.
105. Simpson, J. L., Phipps, S., Gibson, P. G. (2009) Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis. Pharmacol. Ther. 124, 86-95.
106. Wilson, R H., Whitehead, G. S., Nakano, H., Free, M. E., Kolls, J. K, Cook, D. N. (2009) Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 180, 720-730.
107. Prefontaine, D., Lajoie-Kadoch, S., Foley, S., Audusseau, S., Olivenstein, R, Halayko, A J., Lemiere, C, Martin, J. G., Hamid, Q. (2009) Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 183, 5094-5103.
108. Murray, C. S., Poletti, G., Kebadze, T., Morris, J., Woodcock, A, Johnston, S. L., Custovic, A. (2006) Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 61, 376-382.
109. Proud, D., Chow, C. W. (2006) Role of viral infections in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 35, 513-518.
110. Siegle, J. S., Hansbro, N., Herbert, C, Rosenberg, H. F., Domachowske, J. B., Asquith, K L., Foster, P. S., Kumar, R K (2010) Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice. Respir. Res. 11, 14.
111. Kaiko, G. E., Phipps, S., Angkasekwinai, P., Dong, C, Foster, P. S. (2010) NK cell deficiency predisposes to viral-induced Th2-type allergic inflammation via epithelial-derived IL-25. J. Immunol. 185, 4681-4690.
112. Siegle, J. S., Hansbro, N., Dong, C, Angkasekwinai, P., Foster, P. S., Kumar, R K (2011) Blocking induction of T helper type 2 responses prevents development of disease in a model of childhood asthma. Clin. Exp. Immunol. 165, 19-28.
113. Thorne, P. S., Kulhankova, K, Yin, M., Cohn, R, Arbes Jr., S. J., Zeldin, D. C. (2005) Endotoxin exposure is a risk factor for asthma: the na tional survey of endotoxin in United States housing. Am. J. Respir. Crit. Care Med. 172, 1371-1377.
114. Patel, K K, Vicencio, A. G., Du, Z., Tsirilakis, K, Salva, P. S., Webley, W. C. (2010) Infectious Chlamydia pneumoniae is associated with elevated interleukin-8 and airway neutrophilia in children with refractory asthma. Pediatr. Infect. Dis. J. 29, 1093-1098.
115. Webley, W C, Tilahun, Y, Lay, K, Patel, K, Stuart, E. S., Andrzejewski, C, Salva, P. S. (2009) Occurrence of Chlamydia trachomatis and Chla-mydia pneumoniae in paediatric respiratory infections. Eur. Respir. J. 33, 360-367.
116. Dakhama, A, Lee, Y M., Gelfand, E. W. (2005) Virus-induced airway dysfunction: pathogenesis and biomechanisms. Pediatr. Infect. Dis. J. 24, S159-S169.
117. Schaller, M., Hogaboam, C. M., Lukacs, N., Kunkel, S. L. (2006) Respiratory viral infections drive chemokine expression and exacerbate the asthmatic response. J. Allergy Clin. Immunol. 118, 295-302.
118. Bartlett, N. W., Walton, R P., Edwards, M. R, Aniscenko, J., Caramori, G, Zhu, J., Glanville, N., Choy, K J., Jourdan, P., Burnet, J., Tuthill, T. J., Pedrick, M. S., Hurle, M. J., Plumpton, C, Sharp, N. A, Bussell, J. N., Swallow, D. M., Schwarze, J., Guy, B., Almond, J. W., Jeffery, P. K, Lloyd, C. M., Papi, A, Killington, R A, Rowlands, D. J., Blair, E. D., Clarke, N. J., Johnston, S. L. (2008) Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat. Med. 14, 199-204.
119. Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R, Wark, P. A, Bartlett, N. W., Kebadze, T., Mallia, P., Stanciu, L. A., Parker, H. L., Slater, L., Lewis-Antes, A, Kon, O. M., Holgate, S. T., Davies, D. E., Ko-tenko, S. V, Papi, A, Johnston, S. L. (2006) Role of deficient type III interferon-λ production in asthma exacerbations. Nat. Med. 12, 1023-1026.
120. Laza-Stanca, V, Stanciu, L. A, Message, S. D., Edwards, M. R, Gern, J. E., Johnston, S. L. (2006) Rhinovirus replication in human macrophages induces NF-αB-dependent tumor necrosis factor α production. J. Virol. 80, 8248-8258.
121. Ten Hacken, N. H., Oosterhoff, Y, Kauffman, H. F., Guevarra, L., Sa-toh, T., Tollerud, D. J., Postma, D. S. (1998) Elevated serum interferon-γ in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation. Eur. Respir. J. 11, 312-316.
122. Yoshida, M., Watson, R. M., Rerecich, T., O'Byrne, P. M. (2005) Different profiles of T-cell IFN-γ and IL-12 in allergen-induced early and dual responders with asthma. J. Allergy Clin. Immunol. 115, 1004-1009.
123. Wood, L. G., Simpson, J. L., Hansbro, P. M., Gibson, P. G. (2010) Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia. Free Radic. Res. 44, 146-154.
124. Kaiko, G. E., Phipps, S., Hickey, D. K, Lam, C. E., Hansbro, P. M., Foster, P. S., Beagley, K W. (2008) Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity. J. Immunol. 180, 2225-2232.
125. Asquith, K L., Horvat, J. C, Kaiko, G. E., Carey, A J., Beagley, K W., Hansbro, P. M., Foster, P. S. (2011) Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts. PLoS Pat-hog. 7, e1001339.
126. Gotfried, M. H. (2004) Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 125, 52S-60S.
127. Simpson, J. L., Powell, H., Boyle, M. J., Scott, R J., Gibson, P. G. (2008) Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am. J. Respir. Crit. Care Med. 177, 148-155.
128. Shannon, J., Ernst, P., Yamauchi, Y, Olivenstein, R, Lemiere, C, Foley, S., Cicora, L., Ludwig, M., Hamid, Q., Martin, J. G. (2008) Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 133, 420-426.
129. Heaton, T., Rowe, J., Turner, S., Aalberse, R C, de Klerk, N., Suri-yaarachchi, D., Serralha, M., Holt, B. J., Hollams, E., Yerkovich, S., Holt, K, Sly, P. D., Goldblatt, J., Le Souef, P., Holt, P. G. (2005) An immu-noepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet 365, 142-149.
130. Yu, M., Eckart, M. R, Morgan, A. A, Mukai, K, Butte, A. J., Tsai, M., Galli, S. J. (2011) Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma. J. Clin. Invest. 121, 3133-3143.
131. Hakonarson, H., Bjornsdottir, U. S., Halapi, E., Bradfield, J., Zink, F., Mouy, M., Helgadottir, H., Gudmundsdottir, A. S., Andrason, H., Adal-steinsdottir, A. E., Kristjansson, K, Birkisson, I., Arnason, T., Andresdot-tir, M., Gislason, D., Gislason, T., Gulcher, J. R, Stefansson, K (2005) Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients. Proc. Natl. Acad. Sci. USA 102, 14789-14794.
132. Michel, O., Kips, J., Duchateau, J., Vertongen, F., Robert, L., Collet, H., Pauwels, R, Sergysels, R (1996) Severity of asthma is related to endotoxin in house dust. Am. J. Respir. Crit. Care Med. 154, 1641-1646.
133. Locati, M., Deuschle, U., Massardi, M. L., Martinez, F. O., Sironi, M., Sozzani, S., Bartfai, T., Mantovani, A. (2002) Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J. Immunol. 168, 3557-3562.
134. Hayashi, N., Yoshimoto, T., Izuhara, K, Matsui, K, Tanaka, T., Nakani-shi, K (2007) T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-γand IL-13 production. Proc. Natl. Acad. Sci. USA 104, 14765-14770.
135. Yang, M., Kumar, R K, Foster, P. S. (2009) Pathogenesis of steroid-resistant airway hyperresponsiveness: interaction between IFN-γ and TLR4/MyD88 pathways. J. Immunol. 182, 5107-5115.
136. Shi, S., Nathan, C., Schnappinger, D., Drenkow, J., Fuortes, M., Block, E., Ding, A., Gingeras, T. R., Schoolnik, G., Akira, S., Takeda, K., Ehrt, S. (2003) MyD88 primes macrophages for full-scale activation by interferon-γ yet mediates few responses to Mycobacterium tuberculosis. J. Exp. Med. 198, 987-997.
137. Sun, D., Ding, A. (2006) MyD88-mediated stabilization of interferon-7-induced cytokine and chemokine mRNA. Nat. Immunol. 7, 375-381.
138. Szefler, S. J., Norton, C. E., Ball, B., Gross, J. M., Aida, Y., Pabst, M. J. (1989) IFN-γ and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-α is not essential for monocyte priming. J. Immunol. 142, 3985-3992.
139. Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J., et al. (1994) Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263, 1612-1615.
140. Bach, E. A, Aguet, M., Schreiber, R. D. (1997) The IFN γ receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15, 563-591.
141. Ramana, C. V., Gil, M. P., Schreiber, R D., Stark, G. R (2002) Stat1-dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol. 23, 96-101.
142. Pflanz, S., Hibbert, L., Mattson, J., Rosales, R, Vaisberg, E., Bazan, J. F., Phillips, J. H., McClanahan, T. K, de Waal Malefyt, R, Kastelein, R A. (2004) WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172, 2225-2231.
143. Ruckerl, D., Hessmann, M., Yoshimoto, T., Ehlers, S., Holscher, C. (2006) Alternatively activated macrophages express the IL-27 receptor α chain WSX-1. Immunobiology 211, 427-436.
144. Liu, J., Guan, X., Ma, X. (2007) Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-7-mediated pathways. J. Exp. Med. 204, 141-152.
145. Li, J.J., Wang, W., Baines, K J., Bowden, N. A, Hansbro, P. M., Gibson, P. G., Kumar, R K., Foster, P. S., Yang, M. (2010) IL-27/IFN-γ induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages. J. Immunol. 185, 4401-4409.
146. Pflanz, S., Timans, J. C, Cheung, J., Rosales, R, Kanzler, H., Gilbert, J., Hibbert, L., Churakova, T., Travis, M., Vaisberg, E., Blumenschein, W. M., Mattson, J. D., Wagner, J. L., To, W., Zurawski, S., McClanahan, T. K, Gorman, D. M., Bazan, J. F., de Waal Malefyt, R, Rennick, D., Kastelein, R A. (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16, 779-790.
147. Yoshida, H., Hamano, S., Senaldi, G., Covey, T., Faggioni, R, Mu, S., Xia, M., Wakeham, A. C, Nishina, H., Potter, J., Saris, C. J., Mak, T. W. (2001) WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15, 569-578.
148. Morishima, N., Owaki, T., Asakawa, M., Kamiya, S., Mizuguchi, J., Yoshimoto, T. (2005) Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. J. Immunol. 175, 1686-1693.
149. Holscher, C, Holscher, A, Ruckerl, D., Yoshimoto, T., Yoshida, H., Mak, T., Saris, C, Ehlers, S. (2005) The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J. Immunol. 174, 3534-3544.
150. Wang, S., Miyazaki, Y, Shinozaki, Y, Yoshida, H. (2007) Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency. J. Immunol. 179, 6421-6428.
151. Imamichi, T., Yang, J., Huang, D. W., Brann, T. W., Fullmer, B. A, Adelsberger, J. W., Lempicki, R A, Baseler, M. W., Lane, H. C. (2008) IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages. AIDS 22, 39-45.
152. Feng, X. M., Liu, N., Yang, S. G., Hu, L. Y, Chen, X. L., Fang, Z. H., Ren, Q., Lu, S. H., Liu, B., Han, Z. C. (2008) Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleu-kin-27. Biochem. Biophys. Res. Commun. 367, 553-559.
153. Kalliolias, G. D., Ivashkiv, L. B. (2008) IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38. J. Immunol. 180, 6325-6333.
154. Pearl, J. E., Khader, S. A, Solache, A, Gilmartin, L., Ghilardi, N., de-Sauvage, F., Cooper, A. M. (2004) IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J. Immunol. 173, 7490-7496.
155. Berry, M. A, Hargadon, B., Shelley, M., Parker, D., Shaw, D. E., Green, R H., Bradding, P., Brightling, C. E., Wardlaw, A J., Pavord, I. D. (2006) Evidence of a role of tumor necrosis factor a in refractory asthma. N. Engl. J. Med. 354, 697-708.
156. Howarth, P. H., Babu, K S., Arshad, H. S., Lau, L., Buckley, M., McCon-nell, W., Beckett, P., Al Ali, M., Chauhan, A, Wilson, S. J., Reynolds, A., Davies, D. E., Holgate, S. T. (2005) Tumour necrosis factor (TNFα) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 60, 1012-1018.
157. Lukacs, N. W., Strieter, R M., Chensue, S. W., Widmer, M., Kunkel, S. L. (1995) TNF-α mediates recruitment of neutrophils and eosinophils during airway inflammation. J. Immunol. 154, 5411-5417.
158. Scheurich, P., Thoma, B., Ucer, U., Pfizenmaier, K (1987) Immuno-regulatory activity of recombinant human tumor necrosis factor (TNF)-a: induction of TNF receptors on human T cells and TNF-a-me-diated enhancement of T cell responses. J. Immunol. 138, 1786-1790.
159. Franchimont, D., Martens, H., Hagelstein, M. T., Louis, E., Dewe, W., Chrousos, G. P., Belaiche, J., Geenen, V. (1999) Tumor necrosis factor a decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J. Clin. Endocrinol. Metab. 84, 2834-2839.
160. Sullivan, D. E., Ferris, M., Pociask, D., Brody, A. R (2005) Tumor necrosis factor-α induces transforming growth factor-β1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. Am. J. Respir. Cell Mol. Biol. 32, 342-349.
161. Bloom, B. R, Bennett, B. (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153, 80-82.
162. Calandra, T., Bernhagen, J., Mitchell, R A, Bucala, R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179, 1895-1902.
163. Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A, Bacher, M., Donnelly, T., Cerami, A, Bucala, R (1995) MIF as a glucocorticoid-in-duced modulator of cytokine production. Nature 377, 68-71.
164. Roger, T., David, J., Glauser, M. P., Calandra, T. (2001) MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414, 920-924.
165. Calandra, T., Roger, T. (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3, 791-800.
166. Busse, W. W., Lemanske Jr., R F. (2001) Asthma. N Engl. J. Med. 344, 350-362.
167. Bernhagen, J., Krohn, R, Lue, H., Gregory, J. L., Zernecke, A, Koenen, R R, Dewor, M., Georgiev, I., Schober, A, Leng, L., Kooistra, T., Fin-gerle-Rowson, G., Ghezzi, P., Kleemann, R, McColl, S. R, Bucala, R, Hickey, M. J., Weber, C. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13, 587-596.
168. Pan, J. H., Sukhova, G. K, Yang, J. T., Wang, B., Xie, T., Fu, H., Zhang, Y, Satoskar, A. R, David, J. R, Metz, C. N., Bucala, R, Fang, K, Simon, D. I., Chapman, H. A, Libby, P., Shi, G. P. (2004) Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 109, 3149-3153.
169. Ayoub, S., Hickey, M. J., Morand, E. F. (2008) Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis. Nat. Clin. Pract. Rheumatol. 4, 98-105.
170. Rossi, A. G., Haslett, C, Hirani, N., Greening, A. P., Rahman, I., Metz, C. N., Bucala, R, Donnelly, S. C. (1998) Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J. Clin. Invest. 101, 2869-2874.
171. Mizue, Y, Ghani, S., Leng, L., McDonald, C, Kong, P., Baugh, J., Lane, S. J., Craft, J., Nishihira, J., Donnelly, S. C, Zhu, Z., Bucala, R (2005) Role for macrophage migration inhibitory factor in asthma. Proc. Natl. Acad. Sci. USA 102, 14410-14415.
172. Kobayashi, M., Nasuhara, Y, Kamachi, A, Tanino, Y, Betsuyaku, T., Yamaguchi, E., Nishihira, J., Nishimura, M. (2006) Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats. Eur. Respir. J. 27, 726-734.
173. Oboki, K, Ohno, T., Kajiwara, N., Arae, K, Morita, H., Ishii, A, Nambu, A, Abe, T., Kiyonari, H., Matsumoto, K, Sudo, K, Okumura, K, Saito, H., Nakae, S. (2010) IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl. Acad. Sci. USA 107, 18581-18586.
174. Schmitz, J., Owyang, A, Oldham, E., Song, Y, Murphy, E., McClanahan, T. K, Zurawski, G., Moshrefi, M., Qin, J., Li, X., Gorman, D. M., Bazan, J. F., Kastelein, R. A. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490.
175. Liew, F. Y, Pitman, N. I., McInnes, I. B. (2010) Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 10, 103-110.
176. Sakashita, M., Yoshimoto, T., Hirota, T., Harada, M., Okubo, K, Osawa, Y, Fujieda, S., Nakamura, Y, Yasuda, K, Nakanishi, K, Tamari, M. (2008) Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis. Clin. Exp. Allergy 38, 1875-1881.
177. Prefontaine, D., Nadigel, J., Chouiali, F., Audusseau, S., Semlali, A, Cha-kir, J., Martin, J. G., Hamid, Q. (2010) Increased IL-33 expression by epithelial cells in bronchial asthma.J. Allergy Clin. Immunol. 125, 752-754.
178. Kurowska-Stolarska, M., Stolarski, B., Kewin, P., Murphy, G., Corrigan, C. J., Ying, S., Pitman, N., Mirchandani, A, Rana, B., van Rooijen, N., Shepherd, M., McSharry, C, McInnes, I. B., Xu, D., Liew, F. Y (2009) IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 183, 6469-6477.
179. Kondo, Y., Yoshimoto, T., Yasuda, K, Futatsugi-Yumikura, S., Morimoto, M., Hayashi, N., Hoshino, T., Fujimoto, J., Nakanishi, K (2008) Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol. 20, 791-800.
180. Ouyang, W., Kolls, J. K., Zheng, Y (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28, 454-467.
181. Chakir, J., Shannon, J., Molet, S., Fukakusa, M., Elias, J., Laviolette, M., Boulet, L. P., Hamid, Q. (2003) Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression. J. Allergy Clin. Immunol. 111, 1293-1298.
182. Bullens, D. M., Truyen, E., Coteur, L., Dilissen, E., Hellings, P. W., Du-pont, L. J., Ceuppens, J. L. (2006) IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir. Res. 7, 135.
183. McKinley, L., Alcorn, J. F., Peterson, A, Dupont, R. B., Kapadia, S., Logar, A, Henry, A., Irvin, C. G., Piganelli, J. D., Ray, A, Kolls, J. K (2008) TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 181, 4089-4097.
184. Lin, Y, Ritchea, S., Logar, A, Slight, S., Messmer, M., Rangel-Moreno, J., Guglani, L., Alcorn, J. F., Strawbridge, H., Park, S. M., Onishi, R, Nyugen, N., Walter, M. J., Pociask, D., Randall, T. D., Gaffen, S. L., Iwakura, Y, Kolls, J. K, Khader, S. A. (2009) Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31, 799-810.
185. Irusen, E., Matthews, J. G., Takahashi, A, Barnes, P. J., Chung, K. F., Adcock, I. M. (2002) p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J. Allergy Clin. Immunol. 109, 649-657.
186. Rommel, C, Camps, M., Ji, H. (2007) PI3K δ and PI3K γ: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat. Rev. Immunol. 7, 191-201.
187. Marone, R, Cmiljanovic, V., Giese, B., Wymann, M. P. (2008) Targeting phosphoinositide 3-kinase: moving towards therapy. Biochim. Biophys. Acta 1784, 159-185.
188. Erin, E. M., Leaker, B. R, Nicholson, G. C, Tan, A J., Green, L. M., Neighbour, H., Zacharasiewicz, A. S., Turner, J., Barnathan, E. S., Kon, O. M, Barnes, P. J., Hansel, T. T. (2006) The effects of a monoclonal antibody directed against tumor necrosis factor-α in asthma. Am. J. Re-spir. Crit. Care Med. 174, 753-762.
189. Morjaria, J. B., Chauhan, A. J., Babu, K. S., Polosa, R, Davies, D. E., Holgate, S. T. (2008) The role of a soluble TNFα receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial. Thorax 63, 584-591.
190. Wenzel, S. E., Barnes, P. J., Bleecker, E. R, Bousquet, J., Busse, W., Dahlen, S. E., Holgate, S. T., Meyers, D. A, Rabe, K. F., Antczak, A, Baker, J., Horvath, I., Mark, Z., Bernstein, D., Kerwin, E., Schlenker-Her-ceg, R, Lo, K. H., Watt, R, Barnathan, E. S., Chanez, P. (2009) A randomized, double-blind, placebo-controlled study of tumor necrosis fac-tor-a blockade in severe persistent asthma. Am. J. Respir. Crit. Care Med. 179, 549-558.
191. Corren, J., Lemanske, R F., Hanania, N. A, Korenblat, P. E., Parsey, M. V., Arron, J. R, Harris, J. M., Scheerens, H., Wu, L. C, Su, Z., Mo-sesova, S., Eisner, M. D., Bohen, S. P., Matthews, J. G. (2011) Lebriki-zumab treatment in adults with asthma. N. Engl. J. Med. 365, 1088-1098.